Patients Perspective on the Impact of Moderate-to-Severe Genital Psoriasis

Similar documents
The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health

Patients Perspectives on the Impact of Genital Psoriasis: A Qualitative Study

Summer AAD Summer AAD Support provided by LEO Pharma A/S. Poster nº

Evaluating Psoriasis: Patient Reported Outcomes and Impact of Disease

Jashin J Wu, 1 Alexander Egeberg, 2 James A Solomon, 3,4,5 Olawale Osuntokun, 6 Orin Goldblum, 6 Susan R Moriarty, 6 Fangyi Zhao, 6 Neil Korman 7

Abstract Background: Methods: Results: Conclusion:

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis (UNVEIL Phase IV Study)

JEADV SHORT REPORT. Abstract

DLQI (ESTEEM

First Real-World Insights on Apremilast Therapy for Patients With Plaque Psoriasis From the LAPIS-PSO Study: An Interim Analysis

75th AAD Annual Meeting

Bruce Strober 1, 2, Chitra Karki 3, Marc Mason 3, Ning Guo 3, Jeffrey D Greenberg 3,4, Mark Lebwohl 5

Insights from the Kaiser Permanente database

Symptom Severity, Quality of Life and Work Productivity of US Psoriasis Patients During Periods of Flare and Remission

Psoriasis Disease Severity Affects Patient Satisfaction With Therapy

Initiation and evaluation of the effect of biologic treatment. ActaDV ActaDV

P4081 Secukinumab skin clearance is associated with greater improvements in patient-reported pain, itching, and scaling

Topical treatment of psoriasis in difficult to treat areas: Genital, folds and palmoplantar

Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3

Bruce Strober 1, 2, Chitra Karki 3, Marc Mason 3, Jeffrey D Greenberg 3,4, Mark Lebwohl 5

(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)

The Burden of Atopic Dermatitis: from Population to Bedside

Approximately 3% of the US adult population,

WYNNIS L. TOM, MD: And I m Dr. Wynnis Tom. I m Associate Professor of Dermatology and Pediatrics at the University of California, San Diego.

Premature Ejaculation

JEADV SHORT REPORT. Abstract

Association between disease severity and body mass index in psoriasis patients enrolled in the Corrona Psoriasis Registry

WYNNIS L. TOM, MD: And I m Dr. Wynnis Tom. I m Associate Professor of Dermatology and Pediatrics at the University of California, San Diego.

Abstract Background: Methods: Results: Conclusion:

Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC - CP) Pilot results

Cost per Responder of Apremilast Versus Etanercept, Adalimumab, and Ustekinumab in Patients With Moderate to Severe Psoriasis

Economic Evaluation of Apremilast in the Treatment of Moderate to Severe Psoriasis in the United States

To order reprints or e-prints of JDD articles please contact JDD

The Nail Psoriasis Severity Index (NAPSI): Validation of an Instrument to Assess Psoriatic Nail Involvement

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

Mark G. Lebwohl 1 Arthur Kavanaugh

Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?

GOOD IN BED SURVEYS. Report #3. Orgasm

HEY CHARLES, I TOOK YOUR ADVICE AND WENT FOR MC! GREAT, BUT HERE is SOME IMPORTANT info YOU NEED TO REMEMBER! TAKE HOME BOOKLET

Glenmark Pharmaceuticals Inc., USA; Glenmark Pharmaceuticals Ltd., India. Icahn School of Medicine at Mount Sinai, New York, NY, USA;

Incorporating Biologics Into Your Practice

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

Treatment Changes in PaMents with Moderate-to- Severe Psoriasis: A RetrospecMve Chart Review

Active tasks (eg, chores, exercise, swimming, lifting) activities) Choice of clothes (eg, color) Annoyance/anger. Psychological impact.

Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment

JEADV ORIGINAL ARTICLE. Abstract

Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs)

JEADV SHORT REPORT. Abstract

Ohio PREP Region 7 Data Report. Prepared by: Ohio University s Voinovich School of Leadership and Public Affairs January 2018

PGA x BSA as a PASI Surrogate

Source: American Academy of Dermatology Annual Meeting held February 16 20, 2018, in San Diego, California

JEADV ORIGINAL ARTICLE. Abstract

Health Care Professional Questionnaire

Patient reported outcomes in chronic skin diseases: ehealth applications for clinical practice van Cranenburgh, O.D.

Kirklees Museums & Galleries. Volunteer + Culture = Wellbeing?

SEXUALITY AND DIABETES

Daily Oxymetazoline Cream Demonstrates High and Sustained Efficacy in Patients With Persistent Erythema of Rosacea Through 52 Weeks of Treatment

WHI Form 55 Estrogen-Alone Survey Ver. 2

REVEALING A CLEAR PATH TOWARDS A NEW ERA IN THE MANAGEMENT OF PSORIASIS

Client Information for Informed Consent FEMINIZING MEDICATIONS FOR TRANSGENDER CLIENTS

Denial and Unawareness in Huntington s Disease

IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future

Healing Trauma Evaluation Year 1 Findings

Ohio PREP Region 7: Cuyahoga County Board of Health October 2017 through September 2018 Data Report

Emerging Insights in the Treatment of Psoriasis and Psoriatic Arthritis

Do misery and happiness both love company? The emotional consequences of listening to experiences shared by others.

Making Connections: Early Detection Hearing and Intervention through the Medical Home Model Podcast Series

Protecting Your Health: Understanding and Preventing STDs

chemotherapeutic agents in

Having Sex. Some people are heterosexual. Fact Sheet

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study

The transition from independent living to residential care is a significant life event for many older adults

Stroke Impact Scale VERSION 3.0

J. Gelfand 1, A. Joshi 2, D. Shin 1, A. Dey 2, D. Torigian 1, D. Rader 1, M. Playford 2, M. Ahlman 2, A. Alavi 1, N. Mehta 2.

AYPH conference Young peoples experiences of skin conditions Tess McPherson Consultant dermatologist Oxford

FROM REGISTRY DATA TO REAL-LIFE EXPERIENCES: A HOLISTIC PERSPECTIVE OF PSORIASIS TREATMENT

Let s Talk About Clinical Trials: A Discussion Guide for Patients

THINC-it: what is it? John Harrison Alzheimer Center, VU University Medical Center, West London Mental Health Trust, Metis Cognition Ltd

Find your ED cure End your frustration. Renew your confidence. Feel complete. Take the next steps. Erectile dysfunction and heart disease

INSOMNIA SEVERITY INDEX

Diabetes and You. A Quick Guide

UC Davis Dermatology Online Journal

MOR106, an anti-il-17c mab, a potential new approach for treatment of moderate-tosevere atopic dermatitis: Phase 1 study

International Index of Erectile Function Questionnaire IIEF

Sexual Feelings. Having sexual feelings is not a choice, but what you do with your feelings is a choice. Let s take a look at this poster.

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. doi: /bjd.

Public Attitudes and Knowledge about HIV/AIDS in Georgia Kaiser Family Foundation

We believe that young people are all one step away from making a life changing difference for themselves, and each other.

Teen Sexual Health Survey

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

Patterns of social, psychological and spiritual decline towards the end of life in lung cancer and heart failure

Elizabeth Ann Golden, PA-C

Atopic Dermatitis: Emerging therapies. Melinda Gooderham MSc MD FRCPC

Self-harm Workshop. Gemma Fieldsend

Top tips for engaging children and young people of different ages

Presented by: Adelaide A Hebert, MD UTHealth McGovern Medical School, Houston, TX

The symptom recognition and help- seeking experiences of men in Australia with testicular cancer: A qualitative study

Sexual Concerns. Mental Health Topics

Age / Sex: 31-year-old bi-racial male admitted to hospital through. Background:

Moving beyond the big talk

Transcription:

4664 Patients Perspective on the Impact of Moderate-to-Severe Genital Psoriasis Jennifer Clay Cather, 1 Alison Potts Bleakman, 2 April Naegeli, 2 Jiat Ling Poon, 3 Ashley Wallace, 4 Kristin Hollister, 2 Scott Fretzin 4 1 Modern Dermatology, Dallas, USA; 2 Eli Lilly and Company, Indianapolis, USA; 3 Evidera, Bethesda, USA; 4 Dawes & Fretzin Dermatology Group, Indianapolis, USA This study was sponsored by Eli Lilly and Company.

Disclosures J. Cather is in the speaker bureau of: AbbVie, Allergan, Celgene, Janssen, received honoraria from: AbbVie, Eli Lilly and Company, Janssen, Novartis, is a consultant for: AbbVie, Eli Lilly and Company, Janssen, Novartis, is an investigator for: Allergan, Celgene, Cutanea, Dermira, Galderma Labs, GlaxoSmithKline, Janssen, Merck, Novartis, Pfizer, Regeneron, Sandoz, Tolmar Pharma, Vitae, Xenoport, has received grants from: Allergan, Celgene, Cutanea, Dermira, GlaxoSmithKline, Galderma Labs, Janssen, MSD, Novartis, Pfizer, Regeneron, Sandoz, Tolmar Pharma, Vitae, Xenoport, has received other financial benefit from: AbbVie This study was sponsored by Eli Lilly and Company. Medical writing services were provided by Samantha Forster, PhD of ProScribe part of the Envision Pharma Group, and were funded by Eli Lilly and Company

Background and Objective Background Surveys of patients with psoriasis suggest that genital involvement occurs in 29%-63% of the population at some point in the course of the disease 1,2 Data from studies that involve physical examination show that 38% of patients have current genital psoriasis involvement 2,3 Patients with genital psoriasis experience greater impairment in health-related quality of life (HRQoL) and sexual health than patients without genital lesions 2,4 Fewer than 50% of patients with genital psoriasis discuss their symptoms with their physician 5 Better understanding of the impact of genital psoriasis is required to improve the treatment and HRQoL of patients Objective To assess the impact of moderate-to-severe genital psoriasis on sexual health and HRQoL 1. Meeuwis KA, et al. Acta Dermatol Venereol. 2011;91:5-11. 2. Ryan C, et al. J Am Acad Dermatol. 2015;72:978-983. 3. Ji S, et al. Int J Impot Res. 2016;28:96-100. 4. Meeuwis KA, et al. Br J Dermatol. 2011;164:1247-1255. 5. Meeuwis KA, et al. Dermatology. 2012;224;271-276.

Patients and Methods Inclusion Criteria Aged 18 years Physician-diagnosed chronic plaque psoriasis of duration 6 months Involvement of 1% body surface area Past or current genital psoriasis confirmed by dermatologist and self-reported current or recent ( 3 months) moderate-to-severe genital psoriasis (per Patient Global Assessment 4) Response failure or intolerance of 1 topical therapy used for the treatment of genital psoriasis In-depth Patient Interviews One-on-one, semi-structured interviews conducted with patients from 5 US-based clinics Interviews were designed based on literature reviews and clinicians clinical experience of symptom concepts of genital psoriasis that are of greatest clinical relevance to patients Intended to elicit information about genital psoriasis symptoms and their impact on sexual function and HRQoL Patients were given a choice between an in-person interview and a telephone interview Transcripts were coded and analyzed to identify key themes and responses using ATLAS.ti 7.5.9

Baseline Demographics and Characteristics Patients (N=20) Age, years 45 (14.2) Sex, n (%) Male 9 (45) Race, n (%) White Other Duration of disease, a years Psoriasis Genital psoriasis Current moderate-to-severe, b n (%) Psoriasis Genital psoriasis a From diagnosis b Self-reported severity of symptoms. Values are mean (standard deviation) unless otherwise stated 18 (90) 2 (5) 18 (14.0) 7.5 (9.7) 18 (90) 19 (95) All patients indicated preference for a telephone interview

Impact of Genital Psoriasis on Sexual Activity and Sexual Satisfaction, N=20 Sexual Activity Status a Sexual Satisfaction 10% 45% Active 20% 25% Negatively impacted: Very much 45% Not Active Declined to Answer 30% 25% Quite a bit Not at all Other b a Sexual activity was defined to the patient as not limited to sexual intercourse and inclusive of activities such as masturbation. Interviewer phraseology may have varied b Other includes: Somewhat (10%), A little bit (5%), and Have not had genital psoriasis symptoms in the past week (5%) An equal proportion of patients (45%) reported sexual activity and inactivity Genital psoriasis affected sexual satisfaction either very much or quite a bit in 50% of patients

Impact of Genital Psoriasis on Sexual Health Symptom Worsening a Impaired Sexual Experience Reduced Sexual Frequency N=20 patients Impact Reported 80% 80% 80% Avoidance of Sexual Relationships 75% Reduced Sexual Desire 55% Symptom Reported Spontaneous vs. Probed b 60% 65% 35% 60% 10% 20% 15% 45% 15% 45% a Worsening of genital psoriasis symptoms after sexual activity. The presence/absence of each impact was assessed independently of symptom worsening b The interviewer asked probing questions to obtain information regarding specific impacts if not spontaneously mentioned Individual sexual impacts were reported by the majority of patients interviewed Most (90%) spontaneously reported 1 impact of genital psoriasis on sexual health

Representative Patient Quotes: Impacts on Sexual Health if there s patches on the penis itself and you get a full erection, then the skin can tear, so you have to limit [sexual activity] to when that s not the case So sometimes you make a calculated decision as to how badly do I want to engage in this activity given what the cost is going to be and pain and discomfort post activity for hours and/or days if his stuff gets on there, it sets it [my skin] on fire, so you just have to immediately sit in another Epsom salt bath it s just like three days of hell, so it s not worth it to me it s taken it [sexual desire] away just because it s just too painful I told him if it comes between having sex because it s so painful and not being married, then I choose not to be married Selected quotes are from different patients and have been edited to minimize repetitive language

Impact of Genital Psoriasis on HRQoL N=20 patients Impact Reported Negative Impact on: Symptom Reported Spontaneously vs. Probed a Mood/Emotion Physical Activities Daily Activities 95% 70% 60% Social/Leisure Activities 45% Relationships with Friends & Family 45% Work/School 35% 25% 10% 10% 10% 20% 5% 70% 60% 50% 35% 25% 30% a The interviewer asked probing questions to obtain information regarding specific impacts if not spontaneously mentioned The majority of patients expressed HRQoL impacts on mood/emotion (95%), physical activities (70%), and daily activities (60%) Patients were more likely to report impacts on HRQoL after probing, rather than spontaneously

Representative Patient Quotes: Impacts on HRQoL it s affected my life in so many ways What I can wear, what activities I can involve myself in I don t really like to do a whole lot because I am feeling discomfort with the stress, and a lack of confidence whether it be with my partner or just in every day life I m not social any more. I don t get out much. I ve become a recluse if it starts itching or something, it s not seemly that you would, be able to take care of yourself in a public situation running and jogging is something I really I ve had to take [time] off work because I just couldn t stand it even your pants that you don t think are tight are still tight enjoy when that process of cracking and the skin is peeling off you can t jog or run Selected quotes are from different patients and have been edited to minimize repetitive language

Conclusions Nearly all patients reported at least one negative impact on sexual aspects of their quality of life Genital psoriasis was reported to negatively impact patients general well-being, affecting personal relationships and physical, social, and daily activities Patients spontaneously reported sexual health impacts more frequently than they reported general HRQoL impacts Dermatologists are encouraged to discuss the impact of genital psoriasis with patients, as they may disclose more information when asked

Supplementary Information

Interview Guide: Sexual Health 1. Are you sexually active? 2. Have your genital psoriasis symptoms affected your sexual life? a a. How do your genital psoriasis symptoms affect your sexual desire? b. How do your genital psoriasis symptoms physically affect your sexual experience? I. How do genital psoriasis symptoms affect your sexual frequency? II. Do your genital psoriasis symptoms worsen during/following intercourse? a III. Does your genital psoriasis cause you to avoid having sexual relationships? If so, why? Do you avoid sexual relationships due to the: Appearance of your genital psoriasis symptoms? Pain experienced during intercourse? Discomfort experienced during intercourse? Worsening of your genital psoriasis symptoms during intercourse? Way your genital psoriasis makes you feel? a Questions followed by If so, in what way(s)?

Interview Guide: Overall HRQoL Impact 1. How have your genital psoriasis symptoms affected your life in general? Note: Spontaneously reported symptoms were noted first without any probing 2. Which of these symptoms affects your life the most? How? 3. Have your genital psoriasis symptoms affected your physical activities? a 4. Have your genital psoriasis symptoms affected your mood or emotional status? a 5. Have your genital psoriasis symptoms affected your social or leisure activities? a 6. Have your genital psoriasis symptoms affected your work (or school)? a 7. Have your genital psoriasis symptoms affected your daily activities? a 8. Have your relationships with friends or family been affected? a a Questions followed by If so, in what way(s)?